Suministro de Eritropoyetina e Insulina
CONVENIO PARA EL SUMINISTRO DE MEDICAMENTO ERITROPOYETINA E INSULINA POR 24 MESES
7 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1559-510-SE18 | 02-03-2018 | Aventis Pharma Holding Gmbh | $4.977.175 |
| 1559-277-SE18 | 29-01-2018 | Aventis Pharma Holding Gmbh | $4.529.229 |
| 1559-96-SE18 | 08-01-2018 | Novo Nordisk Farmaceutica Limitada | $2.939.300 |
| 1559-10-SE18 | 03-01-2018 | Aventis Pharma Holding Gmbh | $5.723.751 |
| 1559-4363-SE17 | 27-11-2017 | Aventis Pharma Holding Gmbh | $4.618.818 |
| 1559-4362-SE17 | 27-11-2017 | Novo Nordisk Farmaceutica Limitada | $269.535 |
| 1559-4364-SE17 | 27-11-2017 | Megalabs Chile S.A. | $4.202.128 |
| 1559-4031-SE17 | 31-10-2017 | Novo Nordisk Farmaceutica Limitada | $233.597 |
| 1559-4029-SE17 | 31-10-2017 | Aventis Pharma Holding Gmbh | $4.499.366 |
| 1559-3979-SE17 | 26-10-2017 | Megalabs Chile S.A. | $3.778.488 |
| 1559-3945-SE17 | 24-10-2017 | Novo Nordisk Farmaceutica Limitada | $13.226.850 |
| 1559-3623-SE17 | 26-09-2017 | Megalabs Chile S.A. | $3.745.882 |
| 1559-3622-SE17 | 26-09-2017 | Novo Nordisk Farmaceutica Limitada | $1.855.091 |
| 1559-3621-SE17 | 26-09-2017 | Aventis Pharma Holding Gmbh | $4.579.001 |
| 1559-3324-SE17 | 30-08-2017 | Megalabs Chile S.A. | $3.403.400 |
| 1559-3258-SE17 | 24-08-2017 | Aventis Pharma Holding Gmbh | $4.499.366 |
| 1559-3257-SE17 | 24-08-2017 | Novo Nordisk Farmaceutica Limitada | $9.033.528 |
| 1559-2917-SE17 | 28-07-2017 | Megalabs Chile S.A. | $3.332.000 |
| 1559-2922-SE17 | 28-07-2017 | Aventis Pharma Holding Gmbh | $4.529.229 |
| 1559-2923-SE17 | 28-07-2017 | Novo Nordisk Farmaceutica Limitada | $6.466.460 |
| 1559-2515-SE17 | 22-06-2017 | Novo Nordisk Farmaceutica Limitada | $2.351.440 |
| 1559-2516-SE17 | 22-06-2017 | Novo Nordisk Farmaceutica Limitada | $269.535 |
| 1559-2517-SE17 | 22-06-2017 | Aventis Pharma Holding Gmbh | $4.499.366 |
| 1559-2514-SE17 | 22-06-2017 | Megalabs Chile S.A. | $3.427.200 |
| 1559-2119-SE17 | 30-05-2017 | Novo Nordisk Farmaceutica Limitada | $1.829.030 |
| 1559-2125-SE17 | 30-05-2017 | Megalabs Chile S.A. | $3.427.200 |
| 1559-2117-SE17 | 30-05-2017 | Aventis Pharma Holding Gmbh | $4.579.001 |
| 1559-2029-SE17 | 19-05-2017 | Novo Nordisk Farmaceutica Limitada | $1.469.650 |
| 1559-2030-SE17 | 19-05-2017 | Megalabs Chile S.A. | $1.285.200 |
| 1559-1844-SE17 | 03-05-2017 | Novo Nordisk Farmaceutica Limitada | $1.469.650 |
| 1559-1776-SE17 | 27-04-2017 | Aventis Pharma Holding Gmbh | $4.678.545 |
| 1559-1436-SE17 | 05-04-2017 | Novo Nordisk Farmaceutica Limitada | $2.088.569 |
| 1559-1246-SE17 | 28-03-2017 | Aventis Pharma Holding Gmbh | $4.579.001 |
| 1559-1241-SE17 | 27-03-2017 | Megalabs Chile S.A. | $4.403.000 |
| 1559-1111-SE17 | 15-03-2017 | Megalabs Chile S.A. | $2.023.000 |
| 1559-1085-SE17 | 14-03-2017 | Novo Nordisk Farmaceutica Limitada | $1.817.487 |
| 1559-846-SE17 | 02-03-2017 | Aventis Pharma Holding Gmbh | $4.977.175 |
| 1559-848-SE17 | 02-03-2017 | Megalabs Chile S.A. | $1.349.460 |
| 1559-360-SE17 | 27-01-2017 | Novo Nordisk Farmaceutica Limitada | $1.513.740 |
| 1559-358-SE17 | 26-01-2017 | Aventis Pharma Holding Gmbh | $4.479.458 |
| 1559-357-SE17 | 26-01-2017 | Megalabs Chile S.A. | $4.602.920 |
| 1559-5428-SE16 | 29-12-2016 | Novo Nordisk Farmaceutica Limitada | $2.057.510 |
| 1559-5398-SE16 | 27-12-2016 | Megalabs Chile S.A. | $4.921.840 |
| 1559-5397-SE16 | 27-12-2016 | Aventis Pharma Holding Gmbh | $4.579.001 |
| 1559-5164-SE16 | 06-12-2016 | Novo Nordisk Farmaceutica Limitada | $2.526.251 |
| 1559-5133-SE16 | 02-12-2016 | Megalabs Chile S.A. | $4.921.840 |
| 1559-5083-SE16 | 30-11-2016 | Aventis Pharma Holding Gmbh | $4.977.175 |
| 1559-4673-SE16 | 07-11-2016 | Novo Nordisk Farmaceutica Limitada | $1.817.487 |
| 1559-4617-SE16 | 03-11-2016 | Aventis Pharma Holding Gmbh | $3.782.653 |
| 1559-4609-SE16 | 02-11-2016 | Megalabs Chile S.A. | $4.119.780 |
| 1559-4236-SE16 | 03-10-2016 | Novo Nordisk Farmaceutica Limitada | $1.082.662 |
| 1559-4206-SE16 | 30-09-2016 | Aventis Pharma Holding Gmbh | $995.435 |
| 1559-4198-SE16 | 29-09-2016 | Novo Nordisk Farmaceutica Limitada | $1.469.650 |
| 1559-4195-SE16 | 29-09-2016 | Aventis Pharma Holding Gmbh | $4.778.088 |
| 1559-4199-SE16 | 29-09-2016 | Novo Nordisk Farmaceutica Limitada | $587.860 |
| 1559-4141-SE16 | 27-09-2016 | Megalabs Chile S.A. | $2.856.000 |
| 1559-3716-SE16 | 30-08-2016 | Megalabs Chile S.A. | $2.522.800 |
| 1559-3720-SE16 | 30-08-2016 | Novo Nordisk Farmaceutica Limitada | $2.023.238 |
| 1559-3719-SE16 | 30-08-2016 | Aventis Pharma Holding Gmbh | $995.435 |
| 1559-3718-SE16 | 30-08-2016 | Aventis Pharma Holding Gmbh | $3.085.849 |
| 1559-3717-SE16 | 30-08-2016 | Megalabs Chile S.A. | $476.000 |
| 1559-3697-SE16 | 29-08-2016 | Novo Nordisk Farmaceutica Limitada | $881.790 |
| 1559-3571-SE16 | 22-08-2016 | Aventis Pharma Holding Gmbh | $696.805 |
| 1559-3440-SE16 | 12-08-2016 | Novo Nordisk Farmaceutica Limitada | $440.895 |
| 1559-3320-SE16 | 05-08-2016 | Novo Nordisk Farmaceutica Limitada | $1.175.720 |
| 1559-3214-SE16 | 28-07-2016 | Novo Nordisk Farmaceutica Limitada | $573.164 |
| 1559-3215-SE16 | 28-07-2016 | Aventis Pharma Holding Gmbh | $2.637.903 |
| 1559-3177-SE16 | 27-07-2016 | Megalabs Chile S.A. | $2.856.000 |
| 1559-3123-SE16 | 25-07-2016 | Megalabs Chile S.A. | $952.000 |
| 1559-2974-SE16 | 14-07-2016 | Novo Nordisk Farmaceutica Limitada | $881.790 |
| 1559-2777-SE16 | 04-07-2016 | Novo Nordisk Farmaceutica Limitada | $1.381.471 |
| 1559-2733-SE16 | 01-07-2016 | Megalabs Chile S.A. | $159.460 |
| 1559-2738-SE16 | 01-07-2016 | Aventis Pharma Holding Gmbh | $1.990.870 |
| 1559-2737-SE16 | 01-07-2016 | Novo Nordisk Farmaceutica Limitada | $1.053.269 |
| 1559-2680-SE16 | 29-06-2016 | Megalabs Chile S.A. | $2.213.400 |
| 1559-2639-SE16 | 23-06-2016 | Novo Nordisk Farmaceutica Limitada | $587.860 |
| 1559-2595-SE16 | 20-06-2016 | Novo Nordisk Farmaceutica Limitada | $359.380 |
| 1559-2466-SE16 | 14-06-2016 | Novo Nordisk Farmaceutica Limitada | $53.907 |
| 1559-2202-SE16 | 30-05-2016 | Aventis Pharma Holding Gmbh | $5.309.304 |
| 1559-2181-SE16 | 27-05-2016 | Megalabs Chile S.A. | $2.138.430 |
| 1559-2184-SE16 | 27-05-2016 | Novo Nordisk Farmaceutica Limitada | $5.378.919 |
| 1559-1728-SE16 | 03-05-2016 | Novo Nordisk Farmaceutica Limitada | $5.290.740 |
| 1559-1693-SE16 | 30-04-2016 | Novo Nordisk Farmaceutica Limitada | $71.876 |
| 1559-1618-SE16 | 26-04-2016 | Megalabs Chile S.A. | $1.738.590 |
| 1559-1620-SE16 | 26-04-2016 | Aventis Pharma Holding Gmbh | $2.090.414 |
| 1559-1348-SE16 | 13-04-2016 | Aventis Pharma Holding Gmbh | $1.542.924 |
| 1559-1288-SE16 | 07-04-2016 | Aventis Pharma Holding Gmbh | $5.143.388 |
| 1559-1156-SE16 | 30-03-2016 | Megalabs Chile S.A. | $3.017.840 |
| 1559-1158-SE16 | 30-03-2016 | Novo Nordisk Farmaceutica Limitada | $705.432 |
| 1559-753-SE16 | 02-03-2016 | Novo Nordisk Farmaceutica Limitada | $53.907 |
| 1559-752-SE16 | 02-03-2016 | Megalabs Chile S.A. | $3.493.840 |
| 1559-350-SE16 | 29-01-2016 | Novo Nordisk Farmaceutica Limitada | $411.502 |
| 1559-362-SE16 | 29-01-2016 | Megalabs Chile S.A. | $6.045.676 |
| 1559-283-SE16 | 25-01-2016 | Megalabs Chile S.A. | $555.730 |
| 1559-271-SE16 | 22-01-2016 | Novo Nordisk Farmaceutica Limitada | $1.469.650 |
| 1559-89-SE16 | 12-01-2016 | Megalabs Chile S.A. | $191.352 |
| 1559-3-SE16 | 04-01-2016 | Novo Nordisk Farmaceutica Limitada | $3.857.028 |
| 1559-4598-SE15 | 28-12-2015 | Megalabs Chile S.A. | $2.475.676 |
| 1559-4587-SE15 | 23-12-2015 | Megalabs Chile S.A. | $2.522.800 |
| 1559-4431-SE15 | 10-12-2015 | Novo Nordisk Farmaceutica Limitada | $89.845 |
| 1559-4354-SE15 | 09-12-2015 | Megalabs Chile S.A. | $2.142.000 |
Fuente original:ficha mercadopublico.cl
